Deborah P Lavin (Deborah Lavin)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Dna Damage Response

Oxidative Stress

Reactive Oxygen Species

Endoplasmic Reticulum

Top Venues

Molecular cancer research : MCR

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Daryl Griffin, Robbie Carson, Deborah Y Moss, Tamas Sessler, Deborah P Lavin, Vijay K Tiwari, Shivaali Karelia, Richard D Kennedy, Kienan I Savage, Simon S McDade, Adam Carie, Jim Pankovich, Mark Bazett, Sandra Van Schaeybroeck
Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation. Molecular cancer research : MCR (2024)
Daryl Griffin, Robbie Carson, Deborah Y Moss, Tamas Sessler, Deborah P Lavin, Vijay K Tiwari, Shivaali Karelia, Richard D Kennedy, Kienan I Savage, Simon S McDade, Adam Carie, Jim Pankovich, Mark Bazett, Sandra Van Schaeybroeck
Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation. Molecular cancer research : MCR (2024)
Talat H Malik, Daniel P Gitterman, Deborah P Lavin, Hannah J Lomax-Browne, E Christina Hiemeyer, Linda B Moran, Katharina Boroviak, H Terence Cook, Alyssa C Gilmore, Mawj Mandwie, Amina Ahmad, Ian E Alexander, Grant J Logan, Kevin J Marchbank, Allan Bradley, Matthew Caleb Pickering
Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage. Proceedings of the National Academy of Sciences of the United States of America 118 (13) (2021)